Cognetivity Neurosciences (Cognetivity Neurosciences) Total Stockholders Equity : $-11.08 Mil (As of Oct. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Cognetivity Neurosciences Total Stockholders Equity?

Cognetivity Neurosciences's Total Stockholders Equity for the quarter that ended in Oct. 2023 was $-11.08 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Cognetivity Neurosciences's Book Value per Share for the quarter that ended in Oct. 2023 was $-0.12. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Cognetivity Neurosciences's Debt-to-Equity for the quarter that ended in Oct. 2023 was -0.18.

Cognetivity Neurosciences Total Stockholders Equity Historical Data

The historical data trend for Cognetivity Neurosciences's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cognetivity Neurosciences Total Stockholders Equity Chart

Cognetivity Neurosciences Annual Data

Trend

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Total Stockholders Equity

Get a 7-Day Free Trial

0.36

-0.20

0.68

-4.50

-7.37

Cognetivity Neurosciences Quarterly Data
	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23
Total Stockholders Equity	Get a 7-Day Free Trial															-4.95	-7.37	-8.55	-10.09	-11.08

Cognetivity Neurosciences (OTCPK:CGNSF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Cognetivity Neurosciences's Book Value per Share for the quarter that ended in Oct. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-11.082	-	0)	/	89.5566
	=	-0.12

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Cognetivity Neurosciences's Debt-to-Equity for the quarter that ended in Oct. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.998	+	0.998)	/	-11.082
	=	-0.18

Cognetivity Neurosciences Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Cognetivity Neurosciences's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Cognetivity Neurosciences (Cognetivity Neurosciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cognetivity Neurosciences Ltd (OTCPK:CGNSF) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

1UB:Germany CGN:Canada

Address

800 West Pender Street, Suite 1430, Vancouver, BC, CAN, V6C 2V6

Website

https://www.cognetivity.com

Cognetivity Neurosciences Ltd is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical, commercial, and consumer environments for potentially allowing early diagnosis of dementia. The Company is considered operating in one segment for development of the ICA platform. Its geographical areas include Canada, United Kingdom and Dubai.

Cognetivity Neurosciences (Cognetivity Neurosciences) Headlines

From GuruFocus

The Most Innovative Healthcare AI Developments of 2019

By ACCESSWIRE AccessWire • 04-12-2019

Three Companies Using AI and Innovation to Lead Healthcare Sector

By ACCESSWIRE AccessWire • 04-12-2019